Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Researchers.
- Curriculum.
- Publications.
- Projects.
- Patent applications/Patents.
- Presentations.
- Advised theses.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Griesbacher Thomas |

Presentations at scientific and public conferences

Griesbacher, T Towards European training regulations for medical specialists in (clinical) pharmacology in Europe: interim report
N-S ARCH PHARMACOL. 2019; 392: S59-S59. [Poster]
Web of Science

Griesbacher, T Recognition and training of specialists in Clinical Pharmacology in europe: A pilot survey of the UEMS section of pharmacology
N-S ARCH PHARMACOL. . 2018; 391: S57-S57.-84th Annual Meeting of the German-Society-for-Experimental-and-Clinical-Pharmacology-and-Toxicology (DGPT) / 20th Annual Meeting of the Association-of-the-Clinical-Pharmacology-Germany (VKliPha); FEB 26-MAR 01, 2018; Gottingen, GERMANY. [Oral Communication]
Web of Science

Griesbacher, T ACTIVITIES OF EPHAR, EACPT AND UEMS TO SUPPORT TRAINING OF BASIC AND CLINICAL PHARMACOLOGISTS IN EUROPE
BASIC CLIN PHARMACOL. . 2018; 123: 4-4.-1st Meeting in Translational Pharmacology, 38th SEF national meeting/9th SEFF meeting; JUN 19-20, 2018; Santiago de Compostela, SPAIN. [Oral Communication]
Web of Science

Griesbacher, T Recognition and training of medical specialists in (Clinical) Pharmacology in Europe: a pilot survey of the UEMS Section of Pharmacology
Intrinsic Activity. 2017; 5(Suppl1):A6.1-A6.1.-23rd Scientific Symposium of the Austrian Pharacological Society; SEPT 28-29, 2017; Innsbruck, AUSTRIA. [Poster]
FullText

Griesbacher, T Recognition and training of medical specialists in (clinical) pharmacology in Europe
Pharmacology 2017 Abstract Book. 2017; -Pharmacology 2017; DEC 11-13, 2017; London, UNITED KINGDOM. [Poster]

Griesbacher, T Anticholinerges Syndrom - Einfluss auf Delir?
8. Grazer Schmerztag; SEPT 26, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

Griesbacher, T Evaluation of therapeutic benefit as basis for reimbursement by the national social insurance institutions in Austria
7th Adriatic Congress of Pharmacoeconomics and Putcomes Research; Apr 20-23, 2017; Porec, CROATIA. 2017. [Oral Communication]

Griesbacher, T Postgraduate training for medical specialists in pharmacology and toxicology: The Austrian example
Naunyn-Schmiederbergs Arch Pharmacol. 2017; 390(Suppl1):S58-S58.-German Pharm-Tox Summit 2017; MAR 6-9, 2017; Heidelberg, GERMANY. [Poster]
FullText

Griesbacher, T Activities of EPHAR/EACPT and UEMS to support basic and clinical pharmacology in Europe
Joint Annual Meeting of the Hungarian Pharmacological and Physiological Societies 2017; JUN 13-16, 2017; Debrecen, HUNGARY. 2017. [Oral Communication]

Griesbacher, T The European Certified Pharmacologists Programme
Abstract Book Swiss Society of Pharmacology and Toxicology Spring Meeting 2017. 2017; 10-10.-Swiss Society of Pharmacology and Toxicology Spring Meeting 2017; Apr 20, 2017; Bern, SWITZERLAND. [Keynote lecture]

Griesbacher, T Certification of medical specialists in pharmacology and toxicology by the European Certified Pharmacologists (EuCP) Programme
Intrinsic Activity. 2016; 4(S.3):A6.1--Intrinsic Activity; SEP 8-10, 2016; Vienna, AUSTRIA. [Poster]
FullText

Griesbacher, T The EPHAR / EACPT European Certified Pharmacologists Programme (EuCP): update 2016
Intrinsic Activity. 2016; 4(S.1):A2.3--EMBL Conference: Lifelong Learning in the Biomedical Sciences; JUL 5-7, 2016; Heidelberg, GERMANY. [Oral Communication]
FullText

Griesbacher, T Certification within the EPHAR/EACPT European Certified Pharmacologists Programme: the Austriann example
Naunyn-Schmiedebergs Arch Pharmacol. 2016; 389(S.1):S80-S80.-82nd Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) and the 18th Annual Meeting of the Network Clinical Pharmacology Germany (VKliPha) in cooperation with the Arbeitsgemeinschaft für Angewandte Humanpharmakologie e.V. (AGAH); Feb 29 - MAR 3, 2016; Berlin, GERMANY. [Poster]
FullText

Griesbacher, T; Sauermann, R Evaluations of medicines for reimbursement by the national social insurance institutions in Austria
Clinical Therapeutics. 2016; 389(105):e14--EACPT Focus Meeting: How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic – 3E Assessment; OCT 6-9, 2016; Opatija, CROATIA. (ISBN: 0149-2918 ) [Oral Communication]
FullText

Griesbacher, T The European Certified Pharmacologists Programme: an update
Pharmacology 2015; Dec 15-17, 2015; London. 2015. [Oral Communication]

Griesbacher, T The European Certified Pharmacologists (EuCP) program: establishing common standards for postgraduate professional training in pharmacology
N-S ARCH PHARMACOL. 2015; 388: S60-S60.-81st Annual Meeting of the Deutsche-Gesellschaft-für-Experimentelle-und-Klinische-Pharmakologie-und-Toxikologie-e-V; MAR 10-12, 2015; Kiel, GERMANY. [Poster]
Web of Science

Griesbacher, T Defining a discipline: European standards for certification of pharmacologists – the EPHAR EuCP Programme
Proceedings of Pharmacology 2014, 16-18 Dec 2014, London, UK. 2014; 12(3):274P--Pharmacology 2014; DEC 16-18, 2014; London, UK. [Oral Communication]

Griesbacher, T; Drago, F The European Register of Pharmacologists: EPHAR project to support postgraduate professional development in pharmacology in Europe
Abstract Submissions. 2014; -IUPHAR-Ed Pharmacology Education Satellite Meeting; JUL 12-13, 2014; Cape Town, South Africa. [Oral Communication]
FullText

Griesbacher, T; Drago, F European Certified Pharmacologists (EuCP): standards for postgraduate professional training in pharmacology established by EPHAR, the Federation of European Pharmacological Societies
Intrinsic Activity. 2014; 2(Suppl1):A3.1--20th Scientific Symposium of the Austrian Pharmacological Society APHAR; SEPT 26-27, 2014; Innsbruck, Austria. [Oral Communication]
FullText

Griesbacher, T; Drago, F The EPHAR certificate European Registered Pharmacologist (ERP): a project to support postgraduate professional development in pharmacology in Europe.
Basic Clin. Pharmacol. Toxicol.. 2014; 115(Suppl1):323-323.-17th World Congress of Basic and Clinical Pharmacology; JUL 13-18, 2014; Cape Town, South Africa. [Poster]
FullText

Griesbacher, T; Kraneveld, AK The EPHAR certificate European Certified Pharmacologist (EuCP): supporting postgraduate professional development in Europe
FIGON Dutch Medicine Days 2014; 6-8 OCT, 2014; Ede, THE NETHERLANDS. 2014. [Poster]
FullText

Kresse, A, Roller-Wirnsberger, R, Öttl, K, Hofer, A, Griesbacher, T, Wedrich, A Development of a competency-based pregraduate curriculum at Medical University Graz: integration of CanMed roles and Tuning project (medicine) values.
Medical Teacher supplement. 2012; -AMEE meeting; August 25-29, 2012; Lyon, France. [Poster]

Kresse, A; Vogl, S; Roller-Wirnsberger, R; Wagner, D; Hofer, A; Öttl, K; Griesbacher, T; Wedrich A Integrating CanMed, SCLO and Tuning project (Medicine) competencies into the pregraduate Medical education curriculum at Graz Medical University
16th Grazer Konferenz der Lehre; April 19-21, 2012; Timisoara, ROMANIA. 2012. [Poster]
FullText

Griesbacher, T; Holzer, U; Smolle, J; Heinemann, A; Peskar, BA Pharmacology e-learning in an integrated undergraduate curriculum of human medicine
Naunyn-Schmiedeberg's Arch. Pharmacol.2011; 383(S. 1):81--77. Frühjahrstagung der Deutschen Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie; MAR 30 - APR 1, 2011; Frankfurt am Main, GERMANY. [Poster]
Web of Science FullText

Griesbacher, T Bradykinin in Acute Pancreatitis: Friend or Foe?
Research Symposium University of Tampere; FEB 2, 2010; Tampere, FINLAND. 2010. [Keynote lecture]

Griesbacher, T Einfluss von Geschlechtshormonen auf die Signalübertragung
Gender Medicine; APR 24, 2010; Vienna, AUSTRIA. 2010. [Oral Communication]

Griesbacher, T Toleranz, Tachyphylaxie und andere Phänomene
Gender Medicine; APR 24, 2010; Vienna, AUSTRIA. 2010. [Oral Communication]

Griesbacher, T Einfluss von Stress und Stressfaktoren auf die Signalübertagung
Gender Medicine; APR 24, 2010; Vienna, AUSTRIA. 2010. [Oral Communication]

Holzer-Petsche, U; Smolle, J; Griesbacher, T; Heinemann, A; Peskar, BA Pharmacology e learning in an integrated undergraduate curriculum of human medicine
Empowering Effective Teaching in Pharmacology for a Safer Tomorrow; JUL 17-18, 2010; Copenhagen, DENMARK. 2010. [Poster]

Griesbacher, T; Rainer, I; Tiran, B; Evans, DM; Peskar; BA Kallikrein inhibitors limit B2 antagonist-induced progression of oedematous to haemorrhagic pancreatitis in rats
pA2 Online2008; 6(1):026P--EPHAR Congress 2008; JUL 13-17, 2008; Manchester, UK. [Poster]
FullText

Griesbacher, T; Pommer, V; Schuligoi, R; Tiran, B; Peskar, BA Differential anti-inflammatory properties of peroxisome proliferator-activated receptors (PPAR) alpha and gamma in cerulein-induced pancreatitis
PANCREAS. 2007; 35(4):403-404.-American Pancreatic Association Annual Meeting 2007; Nov 1-3, 2007; Chicago, IL, USA. Doi: 10.1097/01.mpa.0000297705.75724.76 [Oral Communication]
Web of Science FullText FullText_MUG

Griesbacher, T; Pommer,V; Schuligoi, R; Peskar BA; Differential anti-inflammatory properties of peroxisome proliferator-activated receptors (PPAR)α and γ in experimental pancreatitis.
BMC Pharmacology 2007; 7 (Suppl 2): A20--APHAR; NOV 22-24; Vienna, Austria. [Poster]

Griesbacher, T; Tiran, B; Peskar, BA The role of peroxisome proliferator-activated receptors alpha (PPAR-alpha) and gamma (PPAR-gamma) in anti-inflammatory actions of perfluorooctanoic acid (PFOA) in experimental acute pancreatitis.
Kinin 2007: 2nd International Conference Exploring the Future of Vascular and Inflammatory Mediators; MAY 30 - JUN 2, 2007; Berlin, GERMANY. 2007. [Poster]

Griesbacher, T; Tiran, B; Peskar, BA Possible role of peroxisome proliferator-activated receptor alpha (Ppar-alpha) in anti-inflammatory actions of perfluorooctanoid acid (Pfoa) in experimental acute pancreatitis
GASTROENTEROLOGY. 2007; 132(4): A253-A253. [Poster]
Web of Science

Griesbacher, T; Evans, DM; Peskar, BA Selective kallikrein inhibitors attenuate hemorrhagic lesions caused by kinin antagonists in experimental acute pancreatitis
ACTA PHARMACOL SIN. 2006; 27: 279-280.-15th World Congress of Pharmacology; JUL 2-7, 2006; Beijing, CHINA. [Poster]
Web of Science

Griesbacher, T; Peskar, BA Anti-inflammatory effects of perfluorooctanoic acid (PFOA) in experimental acute pancreatitis in rats.
Pancreatology. 6: 334-335.-XXXVIII Meeting of the European Pancreatic Club; JUN 7-10, 2006; Tampere, FINLAND. [Oral Communication]

Griesbacher, T; Peskar, BA Effects of perfluorooctanoic acid (PFOA) in cerulein-induced acute pancreatitis in rats.
Pancreas. 33: 464-464.-Joint Meeting of the American Pancreatic Association and the International Association of Pancreatology; NOV 1-4, 2006; Chicago, IL, USA. Doi: 10.1097/00006676-200611000-00096 [Poster]
Web of Science FullText FullText_MUG

Griesbacher, T; Evans, DM; Peskar, BA Selective kallikrein inhibitors attenuate haemorrhagic laesions caused by kinin antagonists in experimental acute pancreatitis
PHARMACOLOGY. 2005; 75: 198-198.-11th Symposium of the Austrian-Pharmacological-Society (Joint Meeting with the Austrian Society of Toxicology and the Hungarian Society for Experimental and Clinical Pharmacology); NOV 24-26, 2005; Vienna, AUSTRIA.
Web of Science

Griesbacher, T; Rainer, I; Schuligoi, R; Peskar, BA Independence of prostaglandin formation and the inflammatory oedema during caerulein-induced acute pancreatitis in rats
PHARMACOLOGY 2004 72: 135-135. [Poster]
Web of Science

Griesbacher, T; Schuligoi, R; Peskar, BA Prostaglandin formation and bradykinin-mediated edema formation during cerulein-induced acute pancreatitis in rats
GASTROENTEROLOGY. 2004; 126(4): A525-A526.
Web of Science

Griesbacher, T; Rainer, I; Heinemann, A; Groisman, D Changes in blood flow in the rat pancreas during exocrine stimulation at submaximal and supramaximal levels
BRIT J PHARMACOL 2003 138: U33-U33.
Web of Science

Groisman, D; Griesbacher, T In vivo characterization of the cholecystokinin CCK1 receptor agonist SR146131 in the rat pancreas
PHARMACOLOGY 2003 69: 214-214.
Web of Science

Griesbacher, T; Peskar, BA; Rainer, I; Fink, E; Evans, DM Mechanisms of kinin release during acute cerulein-induced pancreatitis
GASTROENTEROLOGY 2001 120: A538-A538.
Web of Science

Legat, FJ; Griesbacher, T; Althuber, P; Schuligoi, R; Kerl, H; Wolf, P UVB irradiation with non-erythematogenic doses increases neuropeptides in the skin of rat ears.
PHOTOCHEM PHOTOBIOL 1999 69: 55S-55S.
Web of Science

Griesbacher, T; Lembeck, F; Burchert, M; Peskar, BA Role of the kinin-mediated edema for the accumulation of kinins in the pancreas in experimental pancreatitis.
GASTROENTEROLOGY 1998 114: A464-A464. Doi: 10.1016/S0016-5085(98)81875-1
Web of Science FullText FullText_MUG

Griesbacher, T; Rainer, I Differential effects of a bradykinin B-2 receptor antagonist and dexamethasone on accumulation of activated enzymes during acute pancreatitis
NAUNYN-SCHMIED ARCH PHARMACOL 1998 358: R348-R348.
Web of Science

Griesbacher, T; Tiran, B; Sutliff, RL Accumulation of lysophospholipids in the pancreas of rats during and after cerulein-induced acute pancreatitis: Effects of a bradykinin B-2 antagonist.
FASEB J 1998 12: A260-A260.
Web of Science

Legat, FJ; Griesbacher, T The inflammatory response by a house dust mite extract in non-sensitized rats is caused by 5-hydroxytryptamine from mast cells.
J INVEST DERMATOL 1998 110: 652-652.
Web of Science

Lembeck, F; Griesbacher, T A possible contribution of endogenous kinins in exocrine and vascular functions of the pancreas
NAUNYN-SCHMIED ARCH PHARMACOL 1998 358: R784-R784.
Web of Science

Griesbacher, T Effectivity of the B-2 antagonist FR173657 in models of acute pancreatitis and cystitis in rats
NAUNYN-SCHMIED ARCH PHARMACOL 1997 356: 186-186.
Web of Science

Griesbacher, T Effects of the nonpeptide bradykinin antagonist, FR173657, in experimental models of acute pancreatitis and cystitis in rats
BRIT J PHARMACOL 1997 122: U98-U98.
Web of Science

Sametz, W; Diethart, S; Juan, H; Amann, R; Griesbacher, T Actions of bradykinin involving the activation of primary afferent neurones inhibited by the nonpeptide B-2 receptor antagonist, FR173657.
NAUNYN-SCHMIED ARCH PHARMACOL 1997 355: 292-292.
Web of Science

Griesbacher, T; Legat, FJ FR173657, a new, potent and selective nonpeptide bradykinin antagonist: In vivo studies
NAUNYN-SCHMIED ARCH PHARMACOL 1996 354: 23-23.
Web of Science

Griesbacher, T; Legat, FJ The pharmacology of FR173657, a new, potent and selective non-peptide bradykinin antagonist: In vivo studies in rats and guinea-pigs
BRIT J PHARMACOL 1996 119: P309-P309.
Web of Science

Griesbacher, T; Rainer, I; Griengl, S Contribution of 5-hydroxytryptamine release from mast cells to rat paw oedema induced by wasp venom and synthetic kinins
BRIT J PHARMACOL 1996 117: P89-P89.
Web of Science

Legat, FJ; Sametz, W; Diethart, S; Hammer, S; Griesbacher, T The pharmacology of FR173657, a new, potent and selective non-peptide bradykinin antagonist: In vitro studies in guinea-pig, rat and rabbit tissues
BRIT J PHARMACOL 1996 119: P308-P308.
Web of Science

Legat, FJ; Sametz, W; Diethart, S; Hammer, S; Griesbacher, T FR173657, a new, potent and selective nonpeptide bradykinin antagonist: In vitro studies
NAUNYN-SCHMIED ARCH PHARMACOL 1996 354: 24-24.
Web of Science

↑ Top of page / Navigation